AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11695508 — intervention group
Group type: COMPARATOR
Intervention: High salt diet
Number of subjects: 15
Study 9394942 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone, 1.0 mg/kg, daily
Number of subjects: 24
Study 8205270 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting serum insulin
Number of subjects: 622
Study 8205270 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting serum insulin in Apo E 3/2 individuals
Number of subjects: 622
Study 8205270 — intervention group
Group type: COMPARATOR
Intervention: Fasting serum insulin overall
Number of subjects: 622
Study 3111292 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro15-1788 (Anexate)
Number of subjects: 28
Study 3111292 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 28
Study 11495173 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight control plus cognitive behavioral body image therapy
Number of subjects: 65
Study 11495173 — intervention group
Group type: COMPARATOR
Intervention: Weight control
Number of subjects: 65
Study 31560382 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.1 to 14.0 drinks per week
Number of subjects: 3021
Study 31560382 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 14.0 drinks per week
Number of subjects: 3021
Study 31560382 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily low-quantity drinking
Number of subjects: 3021
Study 31560382 — intervention group
Group type: COMPARATOR
Intervention: Complete abstention
Number of subjects: 3021
Study 30600956 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamines and atorvastatin
Number of subjects: 40
Study 30600956 — intervention group
Group type: COMPARATOR
Intervention: Antihistamines and placebo
Number of subjects: 40
Study 26964644 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min aerobic exercise
Number of subjects: 31
Study 26964644 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min aerobic exercise
Number of subjects: 31
Study 26964644 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min resistance exercise
Number of subjects: 31
Study 26964644 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min resistance exercise
Number of subjects: 31
Study 26964644 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 31
Study 25350130 — intervention group
Group type: EXPERIMENTAL
Intervention: TFV 1% gel (40 mg TFV per 4 ml gel application)
Number of subjects: 18
Study 25350130 — intervention group
Group type: COMPARATOR
Intervention: Oral TDF (300 mg)
Number of subjects: 18
Study 25350130 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl‐cellulose (HEC) placebo gel
Number of subjects: 18
Study 22035157 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg twice weekly (BIW)
Number of subjects: 752
Study 22035157 — intervention group
Group type: COMPARATOR
Intervention: Etanercept 50 mg weekly (QW)
Number of subjects: 752
Study 20375380 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D processed volumes
Number of subjects: 80
Study 20375380 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D processed volumes
Number of subjects: 80
Study 20375380 — intervention group
Group type: COMPARATOR
Intervention: Original volumes
Number of subjects: 80
Study 17602126 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable heroin
Number of subjects: 1015
Study 17602126 — intervention group
Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 1015
Study 16195039 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloured volleyballs
Number of subjects: 20
Study 16195039 — intervention group
Group type: COMPARATOR
Intervention: Plain white volleyballs
Number of subjects: 20
Study 16195039 — intervention group
Group type: EXPERIMENTAL
Intervention: Different colour combinations of volleyballs
Number of subjects: 20
Study 12366624 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative supraphysiological testosterone (600 mg T enanthate intramuscularly weekly for 4 weeks)
Number of subjects: 25
Study 12366624 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sesame oil)
Number of subjects: 25
Study 12366624 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative supraphysiological testosterone
Number of subjects: 25
Study 10404843 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 to 40 mg)
Number of subjects: 2856
Study 10404843 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (10 to 40 mg)
Number of subjects: 2856
Study 7606078 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0
Study 2119796 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative administration of fenbufen
Number of subjects: 38
Study 2119796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 7318331 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of about 70% in salt intake for 24 days
Number of subjects: 0
Study 7318331 — intervention group
Group type: COMPARATOR
Intervention: Control group with no change in salt intake
Number of subjects: 0
Study 30367938 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone insert
Number of subjects: 438
Study 30367938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 438
Study 29251360 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic INR on warfarin
Number of subjects: 3
Study 29251360 — intervention group
Group type: COMPARATOR
Intervention: Subtherapeutic INR on warfarin
Number of subjects: 3
Study 29251360 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulants
Number of subjects: 3
Study 26319650 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (Frequency: 8Hz, pulse duration: 250µs)
Number of subjects: 22
Study 26319650 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-applied TENS (Frequency: 85Hz, pulse duration: 75µs)
Number of subjects: 22
Study 23866673 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard imaging modalities (SPECT)
Number of subjects: 1261
Study 23866673 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced imaging modalities (CMR or PET)
Number of subjects: 1261
Study 23025261 — intervention group
Group type: EXPERIMENTAL
Intervention: Explaining the relevance of activities
Number of subjects: 16
Study 23025261 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing choice from PA options selected by the teacher
Number of subjects: 16
Study 23025261 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing equipment and free choice of activities
Number of subjects: 16
Study 23025261 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 16
Study 20019425 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric Flow
Number of subjects: 105
Study 20019425 — intervention group
Group type: EXPERIMENTAL
Intervention: Grandio Flow
Number of subjects: 105
Study 20019425 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT adhesive
Number of subjects: 105
Study 20019425 — intervention group
Group type: EXPERIMENTAL
Intervention: X-flow
Number of subjects: 105
Study 20019425 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z350 flow
Number of subjects: 105
Study 20019425 — intervention group
Group type: EXPERIMENTAL
Intervention: Admira Flow
Number of subjects: 105
Study 20019425 — intervention group
Group type: EXPERIMENTAL
Intervention: Aelite Flow
Number of subjects: 105
Study 17519410 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulfadoxine‐pyrimethamine
Number of subjects: 601
Study 17519410 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine plus artesunate
Number of subjects: 601
Study 17519410 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether‐lumefantrine
Number of subjects: 601
Study 17519410 — intervention group
Group type: EXPERIMENTAL
Intervention: All study regimens
Number of subjects: 601
Study 15286095 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA 2-093 (200 mg bid)
Number of subjects: 32
Study 15286095 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA 2-093 (400 mg qd)
Number of subjects: 32
Study 15286095 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA 2-093 (800 mg qd)
Number of subjects: 32
Study 15286095 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA 2-093 (1200 mg qd)
Number of subjects: 32
Study 15286095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11380088 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed mitral commissurotomy (CMC)
Number of subjects: 580
Study 11380088 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous mitral balloon valvuloplasty (PMBV)
Number of subjects: 580
Study 9672931 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 100 micrograms.kg‐1
Number of subjects: 80
Study 9672931 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 50 micrograms.kg‐1
Number of subjects: 80
Study 9672931 — intervention group
Group type: EXPERIMENTAL
Intervention: droperidol 60 micrograms.kg‐1
Number of subjects: 80
Study 9672931 — intervention group
Group type: COMPARATOR
Intervention: saline control
Number of subjects: 80
Study 8030593 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with a diet providing 0.8 g protein.kg‐1.d‐1
Number of subjects: 12
Study 8030593 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with a diet providing 1.6 g protein.kg‐1.d‐1
Number of subjects: 12
Study 8030593 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 12
Study 2645063 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg b.i.d.)
Number of subjects: 10
Study 2645063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29545266 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyntomodulin (OXM) 3.0 pmol/kg/min
Number of subjects: 24
Study 29545266 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyntomodulin (OXM)
Number of subjects: 24
Study 29545266 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 24
Study 29545266 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (LIRA)
Number of subjects: 24
Study 28978332 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane with absorbent lattice pad dressing (PAL + Tape)
Number of subjects: 124
Study 28978332 — intervention group
Group type: COMPARATOR
Intervention: Standard polyurethane dressing and sutureless securement device (SPU + SSD) (control)
Number of subjects: 124
Study 28978332 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive (TA + SPU)
Number of subjects: 124
Study 28978332 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination securement-dressing (CSD)
Number of subjects: 124
Study 26362483 — intervention group
Group type: EXPERIMENTAL
Intervention: Vatreptacog alfa
Number of subjects: 72
Study 23201624 — intervention group
Group type: EXPERIMENTAL
Intervention: Masai Barefoot Technology shoes
Number of subjects: 15
Study 23201624 — intervention group
Group type: COMPARATOR
Intervention: Trainer shoes
Number of subjects: 15
Study 21640669 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparoscopic hysterectomy (MLH)
Number of subjects: 76
Study 21640669 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic hysterectomy (LH)
Number of subjects: 76
Study 18290855 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 2.5 mg
Number of subjects: 298
Study 18290855 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg
Number of subjects: 298
Study 18290855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 17154704 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus‐eluting SMART stent
Number of subjects: 93
Study 17154704 — intervention group
Group type: COMPARATOR
Intervention: Bare SMART nitinol stent
Number of subjects: 93
Study 12701975 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketoprofen (100 mg)
Number of subjects: 50
Study 12701975 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study 10924815 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic block in Test‐DOMS group
Number of subjects: 21
Study 10924815 — intervention group
Group type: COMPARATOR
Intervention: Ischaemic block in Ischaemic‐Control group
Number of subjects: 21
Study 10924815 — intervention group
Group type: COMPARATOR
Intervention: Normal‐Control group
Number of subjects: 21
Study 9295178 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg Pergolide at bedtime
Number of subjects: 11
Study 9295178 — intervention group
Group type: COMPARATOR
Intervention: 250 mg L-Dopa + Carbidopa
Number of subjects: 11
Study 8437780 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol
Number of subjects: 130
Study 8437780 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 130
Study 3080935 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin, 60 mg/24 h
Number of subjects: 15
Study 3080935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31661023 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient advocacy organizations' websites providing information on clinical trials
Number of subjects: 118
Study 31661023 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient advocacy organizations' websites providing clinical trial finder or list of relevant trials
Number of subjects: 118
Study 31661023 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient advocacy organizations' websites mentioning expanded access (EA)
Number of subjects: 118
Study 31661023 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient advocacy organizations' websites providing specific resources for FDA's EA program
Number of subjects: 118
Study 31661023 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient advocacy organizations' websites providing a statement on the federal right to try law
Number of subjects: 118
Study 28681394 — intervention group
Group type: EXPERIMENTAL
Intervention: Amenamevir 400 mg
Number of subjects: 751
Study 28681394 — intervention group
Group type: EXPERIMENTAL
Intervention: Amenamevir 200 mg
Number of subjects: 751
Study 28681394 — intervention group
Group type: COMPARATOR
Intervention: Valaciclovir 1000 mg three times daily (control)
Number of subjects: 751
Study 25835379 — intervention group
Group type: EXPERIMENTAL
Intervention: TiF4 gel
Number of subjects: 10
Study 25835379 — intervention group
Group type: EXPERIMENTAL
Intervention: TiF4 gel + CO2 laser
Number of subjects: 10
Study 25835379 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10
Study 25835379 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel + CO2 laser
Number of subjects: 10
Study 23623905 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day discharge after PCI
Number of subjects: 12803
Study 23623905 — intervention group
Group type: COMPARATOR
Intervention: Routine overnight observation
Number of subjects: 12803
Study 23623905 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day discharge after PCI (observational studies)
Number of subjects: 12803
Study 21925293 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 100
Study 21925293 — intervention group
Group type: COMPARATOR
Intervention: Conventional axillary dissection
Number of subjects: 100
Study 19727018 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (5 g of Cr + 15 g maltodextrin, 4 times a day for 5 days)
Number of subjects: 16
Study 19727018 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 g maltodextrin, 4 times a day for 5 days)
Number of subjects: 16
Study 18278530 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous ketamine treatment
Number of subjects: 17
Study 12925501 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance score as a regressor in randomized trials
Number of subjects: 0
Study 12925501 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity link
Number of subjects: 0
Study 12925501 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear links
Number of subjects: 0
Study 12925501 — intervention group
Group type: EXPERIMENTAL
Intervention: Data from two randomized trials
Number of subjects: 0
Study 10774786 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine 12 mg orally for 48 hours
Number of subjects: 20
Study 10774786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8850394 — intervention group
Group type: EXPERIMENTAL
Intervention: Active compression-decompression cardiopulmonary resuscitation (ACD CPR)
Number of subjects: 56
Study 8850394 — intervention group
Group type: COMPARATOR
Intervention: Standard chest compression according to AHA recommendations
Number of subjects: 56
Study 1524079 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-lumen catheter
Number of subjects: 91
Study 1524079 — intervention group
Group type: COMPARATOR
Intervention: Triple-lumen catheter
Number of subjects: 91
Study 6402000 — intervention group
Group type: EXPERIMENTAL
Intervention: Dazoxiben 200 mg four times daily
Number of subjects: 20
Study 4002723 — intervention group
Group type: COMPARATOR
Intervention: Sugar-free tea (0 kcal)
Number of subjects: 180
Study 4002723 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully adapted formula (518 kcal/dl)
Number of subjects: 180
Study 4002723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 180
Study 28674858 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-made cryopreservative fibrin glue (SMC) applied for autograft fixation after pterygium removal.
Number of subjects: 48
Study 26977079 — intervention group
Group type: EXPERIMENTAL
Intervention: Early developmental intervention (EDI)
Number of subjects: 293
Study 26977079 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 293
Study 24887794 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC plus ABRA (VAC-ABRA)
Number of subjects: 14
Study 24887794 — intervention group
Group type: COMPARATOR
Intervention: VAC alone (control)
Number of subjects: 14
Study 22545088 — intervention group
Group type: EXPERIMENTAL
Intervention: ziprasidone (40-160 mg/d)
Number of subjects: 73
Study 22545088 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 73
Study 20731496 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy for Child Abuse and Neglect (MST‐CAN)
Number of subjects: 86
Study 20731496 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Outpatient Treatment (EOT)
Number of subjects: 86
Study 19301515 — intervention group
Group type: EXPERIMENTAL
Intervention: New dentifrice (Colgate Total Advanced Toothpaste) containing 0.3% triclosan/2.0% PVM/MA copolymer/0.243% sodium fluoride in a 17% dual silica base
Number of subjects: 233
Study 19301515 — intervention group
Group type: COMPARATOR
Intervention: Commercially available fluoride dentifrice (Crest Cavity Protection Toothpaste) containing 0.243% sodium fluoride in a silica base
Number of subjects: 233
Study 16005497 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare metal stents
Number of subjects: 59
Study 16005497 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 59
Study 16005497 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 59
Study 16005497 — intervention group
Group type: COMPARATOR
Intervention: Control (Basal concentrations)
Number of subjects: 59
Study 12776900 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical and surgical management options for pain and subfertility
Number of subjects: 0
Study 11912804 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone disease management (ATDM) calls
Number of subjects: 256
Study 8818063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention school lunches
Number of subjects: 5106
Study 8818063 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical education classes
Number of subjects: 5106
Study 8818063 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported dietary, physical activity, and psychosocial measures
Number of subjects: 5106
Study 8818063 — intervention group
Group type: COMPARATOR
Intervention: Physiological measures
Number of subjects: 5106
Study 8818063 — intervention group
Group type: COMPARATOR
Intervention: Measurement error for physiologic measures
Number of subjects: 5106
Study 8818063 — intervention group
Group type: COMPARATOR
Intervention: Coefficients of variation for lipids, height, and weight
Number of subjects: 5106
Study 8818063 — intervention group
Group type: COMPARATOR
Intervention: Intraclass correlations for lipid studies
Number of subjects: 5106
Study 8818063 — intervention group
Group type: COMPARATOR
Intervention: Interobserver agreement scores for SOFIT
Number of subjects: 5106
Study 8818063 — intervention group
Group type: COMPARATOR
Intervention: Data entry error rates
Number of subjects: 5106
Study 1427260 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group receiving the intervention
Number of subjects: 21
Study 1427260 — intervention group
Group type: COMPARATOR
Intervention: Control group discussing current news events
Number of subjects: 21
Study 6330882 — intervention group
Group type: EXPERIMENTAL
Intervention: pivmecillinam
Number of subjects: 30
Study 6330882 — intervention group
Group type: COMPARATOR
Intervention: nitrofurantoin
Number of subjects: 30
Study 30971215 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing drug treatment with ChEIs (with or without memantine)
Number of subjects: 302
Study 30971215 — intervention group
Group type: COMPARATOR
Intervention: Discontinuing drug treatment
Number of subjects: 302
Study 30077197 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxisperm® test
Number of subjects: 38
Study 30077197 — intervention group
Group type: EXPERIMENTAL
Intervention: HaloSperm G2® DNA fragmentation test
Number of subjects: 38
Study 30077197 — intervention group
Group type: EXPERIMENTAL
Intervention: Logit(p) formula based on HaloSperm G2® results
Number of subjects: 38
Study 30077197 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall IVF outcome prediction
Number of subjects: 38
Study 27652698 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenia uniflora dentifrice
Number of subjects: 50
Study 27652698 — intervention group
Group type: COMPARATOR
Intervention: Triclosan-based fluoridated dentifrice (Colgate Total 12)
Number of subjects: 50
Study 24908241 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group (scalp acupuncture and electroacupuncture)
Number of subjects: 250
Study 24908241 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 250